Ethical aspects of genetic testing in the workplace

Community Genetics

Volumn 6, Issue 3, 2003, Pages 136-138

  Holtzman, Neil A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

European Commission; Genetic screening; Genetic testing; Occupation; Workplace

Indexed keywords

BERYLLIOSIS; CARPAL TUNNEL SYNDROME; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; ETHICS; EUROPE; FAMILY HISTORY; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; NEUROPATHY; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; RELIABILITY; REVIEW; RISK ASSESSMENT; UNITED STATES; WORKPLACE;

EUROPEAN COMMISSION; GENETICS AND REPRODUCTION;

BERYLLIOSIS; CHRONIC DISEASE; EUROPE; GENETIC SCREENING; HLA-DP ANTIGENS; HUMANS; UNITED STATES; WORKPLACE;

GOES;

EID: 3142773470     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078160     Document Type: Review

References (11)

1. The European Group on Ethics in Science and New Technologies to the European Commission: Opinion on the Ethical Aspects of Genetic Testing in the Workplace. Opinion No. 18, 28th July 2003. http://europa.eu.int/comm/european_ group_ethics/docs/avis18compl-EN.pdf.
2. Norman-Bloodsaw v. Lawrence Berkeley Laboratory, 135 F.3d 1260. 9th Circuit, 1998.
3. Piitulainen E, Tornling G, Eriksson S: Environmental correlates of impaired lung function in non-smokers with severe alpha-1-antitrypsin deficiency (PiZZ). Thorax 1998;53:939-943.
4. Mayer AS, Stoller JK, Bucher BB, James RA, Sandhaus RA, Newman LS: Occupational exposure risks in individuals with PI*Z alpha(1)-antitrypsin deficiency. Am J Respir Crit Care Med 2000;162:553-558.
5. McCanlies E, Landsittel DP, Yucesoy B, Vallyathan V, Luster ML, Sharp DS: Significance of genetic information in risk assessment and individual classification using silicosis as a case model. Ann Occup Hyg 2002;46:375-381.
6. Holtzman NA: Putting the search for genes in perspective. Int J Health Serv 2001;31:445-461.
7. NIOSH Board of Scientific Counselors: Report of the Subcommittee on Beryllium Research, 2002.
8. Richeldi L, Sorrentino R, Saltini C: HLA-DPB1 glutamate 69: A genetic marker of beryllium disease. Science 1993;262:242-244.
9. Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier LA, Marrone BL: Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. J Immunol 1999;163:1647-1653.
10. Office of Technology Assessment, The Congress of the United States: The Role of Genetic Testing in the Prevention of Occupational Diseases. NTIS order No. PB83-233734. Washington, US Government Printing Office, 1983.
11. Office of Technology Assessment, The Congress of the United States: Genetic Monitoring and Screening in the Workplace. OTA-BA-455. NTIS order No. PB91-105940. Washington, US Government Printing Office, 1990.